Market size, growth to 2033 and clinical trials, side by side.
Germany is the bigger Anesthesia & Respiratory Devices market: $1.1 Bn against $746 Mn in 2023, about 1.4 times as large.
Germany grows faster: 7.7% a year, against 7.5%.
Clinical research: 19 active trials in the UK, 26 in Germany.
| Measure | ||
|---|---|---|
| Market size, 2023 | $746 Mn | $1.1 Bn |
| Market size, 2033 projected | $1.5 Bn | $2.2 Bn |
| Growth a year (CAGR) | 7.5% | 7.7% |
| Money added, 2023–2033 | $792 Mn | $1.2 Bn |
| Share of the world market | 2.6% | 3.7% |
| Size rank of 24 countries | #7 | #5 |
| Market per person, 2023 | $11 | $13 |
| Active clinical trials | 19 | 26 |
| Full report | UK report | Germany report |
UK Germany · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Germany is the bigger Anesthesia & Respiratory Devices market: $1.1 Bn against $746 Mn in 2023, about 1.4 times as large.
Germany grows faster: 7.7% a year, against 7.5%.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.